| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 9 |
| 1 | OMEPRAZOLE | 8 |
| 2 | NUSINERSEN | 7 |
| 3 | RAMIPRIL | 7 |
| 4 | MORPHINE SULFATE | 6 |
| 5 | ERGOCALCIFEROL | 5 |
| 6 | FINASTERIDE | 5 |
| 7 | ADALIMUMAB | 4 |
| 8 | DIAZEPAM | 4 |
| 9 | GABAPENTIN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOMAPACITAN-BECO | 1 | 0.0055 |
| 1 | PALTUSOTINE | 1 | 0.0042 |
| 2 | SETMELANOTIDE | 1 | 0.0035 |
| 3 | BORON | 1 | 0.0033 |
| 4 | NUSINERSEN | 7 | 0.0009 |
| 5 | CLINDAMYCIN HYDROCHLORIDE | 3 | 0.0009 |
| 6 | HYALURONIC ACID | 1 | 0.0009 |
| 7 | ILOPERIDONE | 1 | 0.0007 |
| 8 | DONANEMAB-AZBT | 2 | 0.0007 |
| 9 | CLINDAMYCIN PHOSPHATE TOPICAL | 2 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Antisense Oligonucleotide [EPC] | 7 | 0.0006 |
| 2 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 3 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 5 | Androgen [EPC] | 3 | 0.0001 |
| 6 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 8 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |